Aurora Cannabis Inc.
ACB • Drug Manufacturers - Specialty & Generic
$3.95
▲ +0.06 (+1.54%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$174.68M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.05Healthy liquidity · 5.94Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Jun 11, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.95
Change1.54%
Market Cap$174.68M
52W Range2.56 - 6.67
Beta1.34
Gross Margin42.62%
Oper. Margin-14.55%
Profit Margin-42.41%
Debt/Eq0.05
Current Ratio5.94
Quick Ratio3.32
Target$5.92
Price$3.95
Change1.54%
Market Cap$174.68M
52W Range2.56 - 6.67
Beta1.34
Gross Margin42.62%
Oper. Margin-14.55%
Profit Margin-42.41%
Debt/Eq0.05
Current Ratio5.94
Quick Ratio3.32
Target$5.92
Target Upside49.87%
Target Median$8.00
Target Range1.00 - 8.75
Volume368.59K
Avg Volume1.01M
EPS Surprise0.14
Investment DNA
How strong this company looks for long-term investors
43
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.05Healthy liquidity · 5.94Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-05
Low
$1.00
Mean
$5.92
Median
$8.00
High
$8.75
🧾
No insider activity
No recent insider transactions available.